Abstract:AbstractBackgroundOlfactory dysfunction has been reported for its association with cognitive impairment and incident dementia. However, the underlying role of neurodegeneration in this relationship is not fully understood.MethodThis prospective cohort study included participants from the Shanghai Aging Study (SAS) who were 60 years or older and diagnosed as dementia‐free at baseline and completed at least one follow‐up interview between 2010 and 2022. At baseline, olfactory identification function was assessed by the 12‐item Sniffin’ Sticks Smell test (SSST‐12). Olfactory dysfunction was defined as SSST‐12 < 7, 6, and 5 in three age groups of participants with (age < 70, 70 ≤ age < 80, and age ≥ 80), respectively, according to previously reported normative data of olfaction in the SAS. Baseline blood Neurofilament Light Chain (NfL) was quantified using the ultra‐sensitive Single Molecular Array technology (Quanterix), and dichotomized into low and high levels according to the median concentration. Multiple cognitive function assessments were administered by the Mini‐mental State Examination (MMSE) at baseline and follow‐ups. We used the linear mixed‐effect model to fit the MMSE trajectories in participants with and without olfactory dysfunction adjusting for baseline age, sex, education year, smoking, and APOE ε4, with person‐specific MMSE intercept and slope. Stratified analysis was conducted in participants with low and high NfL.ResultAmong 1125 participants included in this study, 296 were defined as having olfactory dysfunction at baseline. Less education, higher proportion of APOE ε4 allele, and lower baseline and follow‐up MMSE scores were observed in participants with olfactory dysfunction (Table 1). During the median 9.4 years follow‐up, participants with olfactory dysfunction at baseline evidenced a faster MMSE decline compared with those without olfactory dysfunction (b [95% CI]: ‐0.08 [‐0.15, ‐0.02], P = 0.02) (Figure 1). Such association remained statistically significant (‐0.18 [‐0.31, ‐0.06], P = 0.005) in the subgroup with high NfL, but not in the subgroup with low NfL (0.004 [‐0.07, 0.07], P = 0.92) (Figure 2).ConclusionBlood NfL may modify the association of olfactory dysfunction with long‐term cognitive decline in community‐dwelling older adults. In individuals with high potential neurodegeneration, olfactory dysfunction may be an independent indicator of future cognitive deterioration.

Neurofilament light chain is associated with olfactory dysfunction in US adults: findings from National Health and Nutrition Examination Survey

Association between serum neurofilament light chains (sNfL) and neurologic disorders in a representative sample of US adults: a cross-sectional study

Neurofilament Light Chain Modifies the Association of Olfactory Dysfunction with Cognitive Decline: a 12‐year Follow‐up of the Shanghai Aging Study

The association of serum neurofilament light chains with early symptoms related to Parkinson's disease: A cross-sectional study

Association between volatile organic compounds and serum neurofilament light chain in US adults

Serum neurofilament light chain and cognition decline in US elderly: A cross-sectional study

The association between NfL and Cognitive Functioning in older adults diagnosed diabetes: a cross-sectional analysis from NHANES

Elevated Serum Neurofilament Light Chain Levels Are Associated With All-Cause Mortality: Evidence From National Health and Nutrition Examination Survey

Non‐neurological factors associated with serum neurofilament levels in the United States population

Serum neurofilament light chain as a prognostic marker of all-cause mortality in a national sample of US adults

Normative Values for Serum Neurofilament Light Chain in US Adults

Olfactory Function, Genetic Predisposition, and Cognitive Performance in Chinese Adults

Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease

Association of Dietary Retinol Intake and Serum Neurofilament Light Chain Levels: Results from NHANES 2013–2014

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum

Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases

Association between serum neurofilament light chains and depression: A cross-sectional study based on NHANES 2013–2014 database

Associations of plasma neurofilament light chain with cognition and neuroimaging measures in community-dwelling early old age men

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

Predictive value of serum neurofilament light chain for cognitive impairment in Parkinson's disease